Kymriah CAR-T cell therapy demonstrates remarkable efficacy in treating relapsed or refractory follicular lymphoma
Kymriah CAR-T cell therapy demonstrates remarkable efficacy in treating relapsed or refractory follicular lymphoma On December 12, 2021, at the 63rd American Society of Hematology (ASH) Annual Meet...